Quarterly Report

10-Q 1 lwlg_10q.htm QUARTERLY REPORT Quarterly Report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

FORM 10-Q

____________________

(Mark One)


þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2014


¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________to _____________

Commission File Number 0-52567

Lightwave Logic, Inc.

(Exact name of registrant as specified in its charter)

Nevada

(State or other jurisdiction of

Incorporation or Organization)

82-049-7368

(I.R.S. Employer Identification No.)

1831 Lefthand Circle, Suite C

Longmont, CO

(Address of principal executive offices)

80501

(Zip Code)

(720) 340-4949

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):


Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes ¨ No þ

The number of shares of the registrant’s Common Stock outstanding as of November 13, 2014 was 58,364,545.

TABLE OF CONTENTS


			Page

Part I	Financial Information

	Item 1	Financial Statements	1

	Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16

	Item 4	Controls and Procedures	27

Part II	Other Information

	Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	28

	Item 5	Other Information	28

	Item 6	Exhibits	28

		Signatures	29

Forward-Looking Statements

This report on Form 10-Q contains forward-looking statements. Forward-looking statements involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “we believe,” “we intend,” “may,” “should,” “will,” “could” and similar expressions denoting uncertainty or an action that may, will or is expected to occur in the future. These statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from any future results, performances or achievements expressed or implied by the forward-looking statements. You should not place undue reliance on these forward-looking statements.

Factors that that are known to us that could cause a different result than projected by the forward-looking statement, include, but are not limited to: lack of available funding; general economic and business conditions; competition from third parties; intellectual property rights of third parties; regulatory constraints; changes in technology and methods of marketing; delays in completing various engineering and manufacturing programs; changes in customer order patterns; changes in product mix; success in technological advances and delivering technological innovations; shortages in components; production delays due to performance quality issues with outsourced components; those events and factors described by us in Item 1.A “Risk Factors” in our most recent Annual Report on Form 10-K; other risks to which our Company is subject; other factors beyond the Company's control.

Any forward-looking statement made by us in this report on Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

PART I – FINANCIAL INFORMATION

Item 1

Financial Statements

LIGHTWAVE LOGIC, INC.

FINANCIAL STATEMENTS

SEPTEMBER 30, 2014

(UNAUDITED)


		Page

Balance Sheets		2

Statements of Operations		3

Statement of Stockholders’ Equity		4

Statements of Cash Flow		5

Notes to Financial Statements		6

LIGHTWAVE LOGIC, INC.

BALANCE SHEETS


	September 30, 2014			December 31, 2013
	(Unaudited)			(Audited)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	4,213,873		$	2,270,704
Prepaid expenses		171,463			132,204
		4,385,336			2,402,908

PROPERTY AND EQUIPMENT - NET		403,641			298,360

OTHER ASSETS
Intangible assets - net		602,655			543,540

TOTAL ASSETS	$	5,391,632		$	3,244,808


LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable	$	329,295		$	65,410
Accounts payable and accrued expenses- related parties		69,791			48,817
Accrued expenses		103,048			7,949

TOTAL LIABILITIES		502,134			122,176

STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value, 1,000,000 authorized No shares issued or outstanding		—			—
Common stock $0.001 par value, 100,000,000 authorized 58,362,137 and 52,617,789 issued and outstanding at September 30, 2014 and December 31, 2013		58,362			52,618
Additional paid-in-capital		40,349,009			35,414,206
Accumulated deficit		(35,517,873	)		(32,344,192	)

TOTAL STOCKHOLDERS' EQUITY		4,889,498			3,122,632

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	5,391,632		$	3,244,808

See accompanying notes to these financial statements.

LIGHTWAVE LOGIC, INC.

STATEMENTS OF OPERATIONS

FOR THE THREE MONTHS AND NINE MONTHS ENDING SEPTEMBER 30, 2014 AND 2013

(UNAUDITED)


	For the Three Months Ending						For the Nine Months Ending
	September 30,						September 30,
	2014			2013			2014			2013


NET SALES	$	—		$	—		$	2,500		$	—

COST AND EXPENSE
Research and development		741,464			580,403			1,945,357			1,566,901
General and administrative		419,259			417,357			1,214,340			1,298,361
		1,160,723			997,760			3,159,697			2,865,262

LOSS FROM OPERATIONS		(1,160,723	)		(997,760	)		(3,157,197	)		(2,865,262	)

OTHER INCOME (EXPENSE)
Interest income and other income		255			63			378			204
Commitment fee and interest expense		(14,121	)		—			(16,862	)		(204,273	)


NET LOSS	$	(1,174,589	)	$	(997,697	)	$	(3,173,681	)	$	(3,069,331	)

Basic and Diluted Loss per Share	$	(0.02	)	$	(0.02	)	$	(0.06	)	$	(0.06	)

Basic and Diluted Weighted Average Number of Shares		57,854,086			52,046,797			54,717,772			51,417,151

See accompanying notes to these financial statements.

LIGHTWAVE LOGIC, INC.

STATEMENT OF STOCKHOLDERS’ EQUITY

SEPTEMBER 30, 2014

(UNAUDITED)


	Number of		Common		Paid-in		Accumulated
	Shares		Stock		Capital		Deficit			Total

BALANCE AT DECEMBER 31, 2013		52,617,789	$	52,618	$	35,414,206	$	(32,344,192	)	$	3,122,632

Common stock issued to institutional investor		1,063,648		1,065		1,035,083		—			1,036,148
Common stock issued for additional commitment shares		15,630		15		16,847		—			16,862
Common stock issued in private placement		4,207,600		4,207		3,135,793		—			3,140,000
Common stock issued for services		8,470		8		7,992		—			8,000
Exercise of options		35,000		35		10,965		—			11,000
Exercise of warrants		414,000		414		142,416		—			142,830
Options issued for services		—		—		466,671		—			466,671
Warrants issued for services		—		—		119,036		—			119,036
Net loss for the nine months ending September 30, 2014		—		—		—		(3,173,681	)		(3,173,681	)

BALANCE AT SEPTEMBER 30, 2014		58,362,137	$	58,362	$	40,349,009	$	(35,517,873	)	$	4,889,498

See accompanying notes to these financial statements.

LIGHTWAVE LOGIC, INC.

STATEMENTS OF CASH FLOW

FOR THE NINE MONTHS ENDING SEPTEMBER 30, 2014 AND 2013

(UNAUDITED)


	For the Nine Months Ending
	September 30,
	2014			2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(3,173,681	)	$	(3,069,331	)
Adjustment to reconcile net loss to net cash used in operating activities
Warrants issued for services		119,036			108,868
Stock options issued for services		466,671			518,627
Common stock issued for services and fees		24,862			204,274
Depreciation and amortization		110,054			93,441
(Increase) decrease in assets
Receivables		—			—
Prepaid expenses and other current assets		(39,259	)		(55,446	)
Increase (decrease) in liabilities
Accounts payable		263,885			151,084
Accounts payable and accrued expenses- related parties		20,974			42,860
Accrued expenses		95,099			34,583


Net cash used in operating activities		(2,112,359	)		(1,971,040	)

CASH FLOWS FROM INVESTING ACTIVITIES
Cost of intangibles		(70,261	)		(61,216	)
Purchase of equipment, furniture and leasehold improvements		(204,189	)		(106,081	)

Net cash used in investing activities		(274,450	)		(167,297	)

CASH FLOWS FROM FINANCING ACTIVITIES
Issuance of common stock, private placement		3,140,000			—
Issuance of common stock, exercise of options and warrants		153,830			22,525
Issuance of common stock, institutional investor		1,036,148			1,800,000

Net cash provided by financing activities		4,329,978			1,822,525

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		1,943,169			(315,812	)

CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD		2,270,704			2,936,879

CASH AND CASH EQUIVALENTS - END OF PERIOD	$	4,213,873		$	2,621,067

See accompanying notes to these financial statements.

LIGHTWAVE LOGIC, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2014 AND 2013

NOTE 1- NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Financial Statements

The accompanying unaudited financial statements have been prepared by Lightwave Logic, Inc. (the Company). These statements include all adjustments (consisting only of its normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting polices described in the Summary of Accounting Policies included in the 2013 Annual Report. Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission, although the Company firmly believes that the accompanying disclosures are adequate to make the information presented not misleading. The financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission. The interim operating results for the three and nine months ending September 30, 2014 may not be indicative of operating results expected for the full year.

Nature of Business

Lightwave Logic, Inc. is a technology Company focused on the development of next generation photonic devices and non-linear optical polymer materials systems for applications in high speed fiber-optic data communications and optical computing markets. Currently the Company is in various stages of photonic device and materials development and evaluation with potential customers and strategic partners. The Company expects the next revenue stream to be in sales of non-linear optical polymers, prototype devices and product development agreements prior to moving into production.

The Company's current development activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company's technology now under development.

Loss per Share

The Company follows Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 260, "Earnings per Share", resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss in 2014 and 2013, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.

Comprehensive Income

The Company follows FASB ASC 220.10, "Reporting Comprehensive Income." Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since the Company has no items of other comprehensive income, comprehensive income (loss) is equal to net income (loss).

LIGHTWAVE LOGIC, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2014 AND 2013

NOTE 1- NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Recently Issued Accounting Pronouncements Not Yet Adopted

As of September 30, 2014, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.

Recently Adopted Accounting Pronouncements

In June 2014, the FASB issued ASU No. 2014-10, Development Stage Entities (Topic 915), Elimination of Certain Financial Reporting Requirements, including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this Update remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage.

The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations.

The amendments related to the elimination of inception-to-date information and the other remaining disclosure requirements of Topic 915 should be applied retrospectively except for the clarification to Topic 275, which shall be applied prospectively. For public business entities, those amendments are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein.

For public business entities, the amendment eliminating the exception to the sufficiency-of-equity-at-risk criterion for development stage entities in paragraph 810-10-15-16 should be applied retrospectively for annual reporting periods beginning after December 15, 2015, and interim periods therein.

Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued (public business entities) or made available for issuance (other entities). Upon adoption, entities will no longer present or disclose any information required by Topic 915.

The Company adopted the amendments retrospectively beginning in interim period ending June 30, 2014.

LIGHTWAVE LOGIC, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2014 AND 2013

NOTE 2 – MANAGEMENT'S PLANS

As a technology company focusing on the development of the next generation photonic devices and non-linear optical polymer materials systems, substantial net losses have been incurred since inception. The Company has satisfied capital requirements since inception primarily through the issuance and sale of its common stock. The Company currently has a cash position of approximately $3,600,000. Based upon the current cash position and expenditures of approximately $275,000 per month and no debt service, management believes the Company has sufficient funds currently to finance its operations through December 2015. In June 2013, the Company signed an agreement with an institutional investor to sell up to $20 million of common stock. Under the agreement subject to certain conditions and at the Company's sole discretion, the institutional investor has committed to invest up to $20 million in the Company's common stock over a 30-month period with the remaining available amount of $18,485,252. The Company filed a registration statement with the U.S. Securities and Exchange Commission covering the resale of the shares that may be issued to the institutional investor. The Company recently raised $3,140,000 from an equity private placement. Historically the Company has successfully raised sufficient cash to fund its operations.

NOTE 3 – EQUIPMENT

Equipment consists of the following:


	September 30, 2014		December 31, 2013

Office equipment	$	51,322	$	24,244
Lab equipment		501,182		474,049
Furniture		18,782		4,061
Leasehold Improvements		171,576		37,519
		742,862		539,873
Less: Accumulated depreciation		339,221		241,513

	$	403,641	$	298,360

Depreciation expense for the nine months ending September 30, 2014 and 2013 was $98,908 and $82,295. Depreciation expense for the three months ending September 30, 2014 and 2013 was $34,837 and $30,393.

LIGHTWAVE LOGIC, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2014 AND 2013

NOTE 4 – INTANGIBLE ASSETS

This represents legal fees and patent fees associated with the prosecution of patent applications. The Company has recorded amortization expenses on the Spacer and Chromophore patents granted by the United States Patent and Trademark Office in February 2011, April 2011 and September 2012, which are amortized over its legal life of 20 years and Chromophore patent granted by the Australian Patent Office in November 2012 which is amortized over its legal life of 20 years. Certain patent applications are abandoned by the Company when the claims are covered by patents already granted to the Company. Patent applications abandoned have been written off at full capitalized cost. No amortization expense has been recorded on the remaining patent applications since patents have yet to be granted. Once the patents are granted, the cost of the patents will be amortized over their legal lives, which is generally 20 years.

Patents consists of the following:


	September 30, 2014		December 31, 2013

Patents	$	649,496	$	579,235
Less: Accumulated amortization		46,841		35,695

	$	602,655	$	543,540

Amortization expense for the nine months ending September 30, 2014 and 2013 was $11,146 and $11,146. Amortization expense for the three months ending September 30, 2014 and 2013 was $3,715 and $3,715. Expense for abandoned patents for claims covered by patents already granted to the Company are recorded in research and development expenses and for the three months and nine months ending September 30, 2014 and 2013 were $0 and $0.

NOTE 5 – INCOME TAXES

There is no income tax benefit for the losses for the three and nine months ended September 30, 2014 and 2013 since management has determined that the realization of the net deferred tax asset is not assured and has created a valuation allowance for the entire amount of such benefits.

The Company's policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of January 1, 2014, the Company had no unrecognized tax benefits, or any tax related interest of penalties. There were no changes in the Company's unrecognized tax benefits during the period ended September 30, 2014. The Company did not recognize any interest or penalties during 2014 related to unrecognized tax benefits. With few exceptions, the U.S. and state income tax returns filed for the tax years ending on December 31, 2010 and thereafter are subject to examination by the relevant taxing authorities.

LIGHTWAVE LOGIC, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2014 AND 2013

NOTE 6 – STOCKHOLDERS' EQUITY

Preferred Stock

Pursuant to the Company's Articles of Incorporation, the Company's board of directors is empowered, without stockholder approval, to issue series of preferred stock with any designations, rights and preferences as they may from time to time determine. The rights and preferences of this preferred stock may be superior to the rights and preferences of the Company's common stock; consequently, preferred stock, if issued could have dividend, liquidation, conversion, voting or other rights that could adversely affect the voting power or other rights of the common stock. Additionally, preferred stock, if issued, could be utilized, under special circumstances, as a method of discouraging, delaying or preventing a change in control of the Company's business or a takeover from a third party.

Common Stock and Warrants

In January 2009, an employee was granted with an option to purchase up to 25,000 shares of common stock at a purchase price of $.25 per share. Using the Black-Scholes Option Pricing Formula, the options were valued at $13,136, fair value. These options expire in 5 years and vest immediately. The expense recognized during 2009 is $13,136. In May 2010, the option was partially exercised to purchase 15,000 shares of common stock for proceeds of $3,750. In January 2014, the remaining 10,000 options were exercised to purchase 10,000 shares of common stock for proceeds of $2,500.

In June 2009, an employee was granted with an option to purchase up to 25,000 shares of common stock at a purchase price of $.34 per share. Using the Black-Scholes Option Pricing Formula, the options were valued at valued at $21,085, fair value. These options expire in 5 years and vest immediately. The expense recognized during 2009 is $21,085. In May 2014, the option was fully exercised to purchase 25,000 shares of common stock for proceeds of $8,500.

During June 2009, the Company issued a warrant to purchase 464,000 shares of common stock at a purchase price of $0.34 per share for accounting services rendered. The warrant was valued at $391,342 using the Black-Scholes Option Pricing Formula, vesting 46,400 immediately and the remaining on equal monthly installments of 23,200 over the next eighteen months. The warrant expires in 5 years. The expense is being recognized based on service terms of the agreement over a twenty two month period. The expense recognized during 2010 and 2009 is $213,459 and $177,883. In April 2010, the warrant was partially exercised to purchase 10,000 shares of common stock for proceeds of $3,450. In February 2012, the warrant was partially exercised to purchase 20,000 shares of common stock for proceeds of $6,900. In June 2013, the warrant was partially exercised to purchase 20,000 shares of common stock for proceeds of $6,900. In March 2014, warrants were exercised to purchase 250,000 shares of common stock for proceeds of $86,250. In June 2014, the remaining outstanding 164,000 warrants were exercised to purchase 164,000 shares of common stock for proceeds of $56,580.

In January 2011, the Company issued a warrant to a related party to purchase 10,000 shares of common stock for legal services at an exercise price of $1.25 per share. Using the Black-Scholes Option Pricing Formula, the warrants were valued at $10,453, fair value. These warrants expire in 3 years and vest immediately. The expense recognized during 2011 is $10,453. In January 2014, the warrant to purchase 10,000 shares of common stock forfeited.

In August 2012, the board of directors approved a grant to a new employee of an option to purchase up to 100,000 shares of common stock at a purchase price of $0.925 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $74,486, fair value. The option expires in 5 years with 12,500 vesting every 3 months from date of grant. The option is expensed over the vesting terms. For the years ending December 31, 2013 and 2012, the Company recognized $37,242 and $15,611 of expense. For the three and nine months ending September 30, 2014, the Company recognized $0 and $3,012 of expense. In February 2014, the option to purchase 25,000 shares of common stock forfeited. In May 2014, the option to purchase 75,000 shares of common stock forfeited.

LIGHTWAVE LOGIC, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2014 AND 2013

NOTE 6 – STOCKHOLDERS' EQUITY (CONTINUED)

Common Stock and Warrants (Continued)

In May 2013, the board of directors approved a grant to a new employee of an option to purchase up to 10,000 shares of common stock at a purchase price of $1.03 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $9,574, fair value. The option expires in 10 years with 1,250 vesting quarterly from date of grant. The option is expensed over the vesting terms. In December 2013, the option to purchase 7,500 shares of common stock forfeited. For the year ending December 31, 2013, the Company recognized a net expense of $2,394. For the nine months ending September 30, 2014, the Company recognized $0 of expense. In March 2014, the options to purchase 2,500 shares of common stock forfeited.

In June 2013, the Company signed a Purchase Agreement and Registration Rights Agreement with an institutional investor to sell up to $20 million of common stock. Under the agreement subject to certain conditions and at the Company's sole discretion, the institutional investor has committed to invest up to $20 million in the Company's common stock over a 30-month period. The Company filed the registration statement with the U.S. Securities and Exchange Commission in September 2013. The institutional investor is obligated to make purchases as the Company directs in accordance with the agreement, which may be terminated by the Company at any time, without cost or penalty. Sales of shares will be made in specified amounts and at prices that are based upon the market prices of the Company's common stock immediately preceding the sales to the institutional investor. The Company issued 200,000 shares of restricted common stock to the institutional investor as an initial commitment fee valued at $170,000, fair value and 400,000 shares of common stock are reserved for additional commitment fees to the institutional investor in accordance with the terms of the agreement. During June 2013 through September 2014, the institutional investor purchased 1,563,648 shares of common stock for proceeds of $1,514,647 and the Company issued 23,272 shares of common stock as additional commitment fee, valued at $24,745, fair value, leaving 376,728 in reserve for additional commitment fees. For the nine months ending September 30, 2014, the institutional investor purchased 1,063,648 shares of common stock for proceeds of $1,036,148 and the Company issued 15,630 shares of common stock as additional commitment fee, valued at $16,862, fair value. For the three months ending September 30, 2014, the institutional investor purchased 863,648 shares of common stock for proceeds of $858,487 and the Company issued 12,950 shares of common stock as additional commitment fee, valued at $14,121, fair value.

In December 2013, the board of directors approved a grant to a senior advisor effective January 2014 of a warrant to purchase up to 100,000 shares of common stock at a purchase price of $0.715 per share. Using the Black-Scholes Option Pricing Formula, the warrant was valued at $53,313, fair value. The warrant expires in 5 years and vests 25,000 immediately and the remaining in equal monthly installments of 7,500 over the next 10 months. The warrant is expensed over the vesting terms. For the nine month ending September 30, 2014, the Company recognized $39,876 of expense. For the three month ending September 30, 2014, the Company recognized $13,438 of expense. As of September 30, 2014, the warrants to purchase 100,000 shares of common stock are still outstanding.

LIGHTWAVE LOGIC, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2014 AND 2013

NOTE 6 – STOCKHOLDERS' EQUITY (CONTINUED)

Common Stock and Warrants (Continued)

In January 2014, the Company issued options to the Company's 4 independent directors to each purchase 50,000 shares of common stock at a purchase price of $0.715 per share. The options were each valued at $29,440, fair value, using the Black-Scholes Option Pricing Formula. The options expire in 10 years with 20,000 vesting immediately and the remainder vesting in quarterly equal installments of 10,000 commencing April 1, 2014. The options are expensed over the vesting terms. For the nine month ending September 30, 2014, the Company recognized $117,760 of expense. For the three month ending September 30, 2014, the Company recognized $23,812 of expense. As of September 30, 2014, the options to purchase 200,000 shares of common stock are still outstanding.

In March 2014, the Company issued options to a new employee to purchase 30,000 shares of common stock at a purchase price of $0.92 per share. The options were valued at $23,304, fair value, using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 3,750 from date of employment. The options are expensed over the vesting terms. For the nine month ending September 30, 2014, the Company recognized $7,187 of expense. For the three month ending September 30, 2014, the Company recognized $2,913 of expense. As of September 30, 2014, the options to purchase 30,000 shares of common stock are still outstanding.

In March 2014, the Company issued options to a new employee to purchase 75,000 shares of common stock at a purchase price of $0.92 per share. The options were valued at $58,384, fair value, using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 9,375 from date of employment. The options are expensed over the vesting terms. For the nine month ending September 30, 2014, the Company recognized $17,531 of expense. For the three month ending September 30, 2014, the Company recognized $7,298 of expense. As of September 30, 2014, the options to purchase 75,000 shares of common stock are still outstanding.

In March 2014, the Company issued options to a new employee to purchase 50,000 shares of common stock at a purchase price of $0.92 per share. The options were valued at $38,922, fair value, using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 6,250 from date of employment. The options are expensed over the vesting terms. For the nine month ending September 30, 2014, the Company recognized $11,228 of expense. For the three month ending September 30, 2014, the Company recognized $4,862 of expense. As of September 30, 2014, the options to purchase 50,000 shares of common stock are still outstanding.

In March 2014, the Company issued options to an employee to purchase 125,000 shares of common stock at a purchase price of $0.92 per share. The options were valued at $96,211, fair value, using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 15,625 commencing April 1, 2014. The options are expensed over the vesting terms. For the nine month ending September 30, 2014, the Company recognized $35,949 of expense. For the three month ending September 30, 2014, the Company recognized $12,028 of expense. As of September 30, 2014, the options to purchase 125,000 shares of common stock are still outstanding.

In March 2014, the Company issued options to an employee to purchase 30,000 shares of common stock at a purchase price of $0.92 per share. The options were valued at $22,222, fair value, using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 7,500 commencing April 1, 2014. The options are expensed over the vesting terms. For the nine month ending September 30, 2014, the Company recognized $16,606 of expense. For the three month ending September 30, 2014, the Company recognized $5,556 of expense. As of September 30, 2014, the options to purchase 30,000 shares of common stock are still outstanding.

LIGHTWAVE LOGIC, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2014 AND 2013

NOTE 6 – STOCKHOLDERS' EQUITY (CONTINUED)

Common Stock and Warrants (Continued)

In March 2014, the Company issued options to purchase 40,000 shares of common stock at a purchase price of $0.92 per share to its Chief Executive Officer as part of a new employment agreement. The options were valued at $29,630, fair value, using the Black-Scholes Option Pricing Formula. The options expire in 10 years vesting in quarterly equal installments of 10,000 commencing April 1, 2014. The options are expensed over the vesting terms. For the nine month ending September 30, 2014, the Company recognized $22,142 of expense. For the three month ending September 30, 2014, the Company recognized $7,408 of expense. As of September 30, 2014, the options to purchase 40,000 shares of common stock are still outstanding.

In March 2014, the Company issued warrants to purchase 100,000 shares of common stock for consulting services at an exercise price of $0.92 per share. The warrants were valued at $66,936, fair value, using the Black-Scholes Option Pricing Formula. The warrants expire in 5 years vesting 25,000 immediately with the remaining 75,000 vesting in monthly equal installments of 7,500 commencing April 1, 2014. The warrants are expensed over the vesting terms. For the nine month ending September 30, 2014, the Company recognized $38,878 of expense. For the three month ending September 30, 2014, the Company recognized $16,872 of expense. As of September 30, 2014, the warrants to purchase 100,000 shares of common stock are still outstanding. In October 2014, warrants to purchase 22,500 shares of common stock forfeited.

In May 2014, the Company issued options to a new director to purchase 200,000 shares of common stock at a purchase price of $0.763 per share. The options were valued at $122,515 using the Black-Scholes Option Pricing Formula. The options expire in 10 years with 50,000 vesting immediately and the remainder vesting in annual equal installments of 50,000 commencing on the one year anniversary of the date of grant. The options are expensed over the vesting terms. For the nine month ending September 30, 2014, the Company recognized $42,544 of expense. For the three month ending September 30, 2014, the Company recognized $7,720 of expense. As of September 30, 2014, the option to purchase 200,000 shares of common stock are still outstanding.

During June 2014 through August 2014, the Company issued 4,207,600 shares of common stock and warrants to purchase 4,207,600 shares of common stock expiring five years from the date of purchase, for proceeds of $3,140,000 in accordance to a private placement memorandum as amended on May 27, 2014. Pursuant to the terms of the offerings, up to 60 units were offered at the purchase price of $50,000 per unit, with each unit comprised of 67,000 shares and a warrant to purchase 33,500 shares of common stock at $1.00 per share and a warrant to purchase 33,500 shares of common stock at $1.25 per share. The warrants to purchase 2,103,800 shares of common stock at $1.00 per share are still outstanding as of September 30, 2014. The warrants to purchase 2,103,800 shares of common stock at $1.25 per share are still outstanding as of September 30, 2014. Since the warrants are considered indexed to its own stock and qualify for equity classification, there is no requirement to separately account for the warrants.

During June 2014, July 2014, August 2014 and September, 2014 the Company issued 2,371, 2,081, 1,897, and 2,121 shares of common stock, respectively to a director serving as a member of the Company's Operations Committee valued each issuance at $2,000, fair value. For the nine month ending September 30, 2014, the Company recognized $8,000 of expense. For the three month ending September 30, 2014, the Company recognized $6,000 of expense. During October 2014, the Company issued 2,408 shares of common stock to the director serving as a member of the Company's Operations Committee valued at $2,000, fair value.

LIGHTWAVE LOGIC, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2014 AND 2013

NOTE 6 – STOCKHOLDERS' EQUITY (CONTINUED)

Common Stock and Warrants (Continued)

During July 2014, the Company issued a warrant to purchase 100,000 shares of common stock at a purchase price of $0.95 per share for accounting services rendered commencing July 1, 2014. The warrant was valued at $63,576 using the Black-Scholes Option Pricing Formula, vesting over the next twelve months with 8,333 vesting immediately, 8,333 vesting per month on the first day of the next ten months and 8,337 vesting on the first day of the twelfth month of the corresponding service agreement. The warrant expires in five years. The expense is being recognized based on service terms of the agreement over a twelve month period. For the three and nine month ending September 30, 2014, the Company recognized $16,025 of expense. As of September 30, 2014, the warrants to purchase 100,000 shares of common stock are still outstanding.

NOTE 7 – STOCK BASED COMPENSATION

The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award, with the following assumptions for 2014: no dividend yield, expected volatility, based on the Company's historical volatility, 84% to 109%, risk-free interest rate 1.46% to 2.08% and expected option life of 5 to 7.25 years.

As of September 30, 2014, there was $473,036 of unrecognized compensation expense related to non-vested market-based share awards that is expected to be recognized through May 2017.

The following tables summarize all stock option and warrant activity of the Company during the nine months ended September 30, 2014:


	Non-Qualified Stock Options and Warrants Outstanding and Exercisable
						Weighted
	Number of			Exercise		Average
	Shares			Price		Exercise Price

Outstanding, December 31, 2013		7,146,000		$	0.25 - $1.75	$	1.16

Granted		5,257,600		$	0.72 - $1.25	$	1.07
Expired		(10,000	)	$	1.25	$	1.25
Forfeited		(102,500	)	$	0.925 - $1.03	$	0.93
Exercised		(449,000	)	$	0.25 - $0.345	$	0.34

Outstanding, September 30, 2014		11,842,100		$	0.63 - $1.75	$	1.15

Exercisable, September 30, 2014		10,993,349		$	0.63 - $1.75	$	1.17


Non-Qualified Stock Options and Warrants Outstanding
			Weighted Average
	Number Outstanding	Weighted Average	Exercise Price of
Range of	Currently Exercisable	Remaining	Options and Warrants
Exercise Prices	at September 30, 2014	Contractual Life	Currently Exercisable

$0.63 - $1.75	10,993,349	3.65 Years	$ 1.17

LIGHTWAVE LOGIC, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2014 AND 2013

NOTE 8 – RELATED PARTY

At September 30, 2014 the Company had accrued salaries to two beneficial owners of $42,088, legal accrual to related party of $25,355 and travel and office expense accruals of officers in the amount of $2,348. At December 31, 2013 the Company had accrued salaries to two beneficial owners of $42,088, legal accrual to related party of $5,500 and travel and office expense accruals of officers in the amount of $1,229.

NOTE 9 – RETIREMENT PLAN

During 2013, the Company established a 401(k) retirement plan covering all eligible employees beginning November 15, 2013. There were no contributions charged to expense.

NOTE 10 – SUBSEQUENT EVENTS

During November 2007, under the 2007 Employee Stock Option Plan, the Company issued options to purchase 1,752,000 shares of common stock at a purchase price of $0.72 per share. The options expire in 5 years with 146,000 shares vesting each quarter from date of grant. During 2008, an option to purchase 750,000 shares of common stock, of which 125,000 shares were vested, forfeited. In November 2012, the remaining options were extended to November 2014. In October 2014, the remaining options were extended to November 2016. The incremental increase in fair value of the modified options was $245,082 using the Black-Scholes Option Pricing Formula which was expensed immediately.

In January 2008, under the 2007 Employee Stock Option Plan, the Company issued an option to purchase 100,000 shares of common stock at a purchase price of $0.72 per share, vesting 25,000 immediately and the remaining in annual equal installments of 25,000. In November 2012, the option was extended to January 2015. In October 2014, the option was extended to January 2017. The incremental increase in fair value of the modified options was $21,462 using the Black-Scholes Option Pricing Formula which was expensed immediately.

Item 2

Management's Discussion and Analysis of Financial Condition and Results of Operations

Lightwave Logic, Inc. (the “Company”) is a development stage technology company focused on the development of next generation photonic devices and non-linear optical polymer materials systems for applications in high speed fiber-optic data communications and optical computing markets. Our primary area of expertise is the chemical synthesis of chromophore dyes used in the development of organic Application Specific Electro-Optic Polymers (ASEOP) and Organic Non-Linear All-Optical Polymers (NLAOP) that have high electro-optic and optical activity. Our family of materials are both thermally and photo-chemically stable, which we believe could have utility across a broad range of applications in devices that address markets like, telecommunication, data communications, high-speed computing and photovoltaic cells. Secondarily, the Company is developing proprietary electro-optical and all-optical devices utilizing the advanced capabilities of our materials for the application in the fields mentioned above.

In order to transmit digital information at extremely high-speeds (wide bandwidth) over the Internet, it is necessary to convert the electrical signals produced by a computer into optical signals for transmission over long-distance fiber-optic cable. Molecularly engineered materials known as electro-optic polymers when designed into optical devices perform the actual conversion of an electrical signal to an optical signal.

We are currently developing electro-optic polymers that promise performance many times faster than any technology currently available and that have unprecedented thermal stability. High-performance electro-optic materials produced by our Company have demonstrated stability as high as 350 degrees Celsius. Stability above 250 degrees Celsius is necessary for vertical integration into many semi-conductor production lines. In December 2011 one of our non-linear optical polymers, Perkinamine Indigo^TM demonstrated an unusually high electro-optical effect of greater than 250 picometers per volt on 1.5-micron films with excellent thermal and photo stability. Independent research laboratories at Photon-X and The University of Colorado confirmed these characteristics. We continued our development program on Perkinamine Indigo^TM to better understand the properties that gave us the results reported in December 2011. In January 2014 we created a new methodology to combine multiple chromophores into a single polymer host that we anticipated would significantly improve their ability to generate more powerful organic, nonlinear electro-optical (EO) polymer systems. The new synthetic chemistry process enabled multiple chromophores (dyes) to work in concert with each other within a single polymer host. This proprietary process created two new material systems, which have demonstrated outstanding electro-optic values. In addition, initial thermal stability results exceed any commercially available organic nonlinear polymer material systems.

Our non-linear all optical polymers have demonstrated resonantly enhanced third-order properties about 2,630 times larger than fused silica, which means that they are very photo-optically active in the absence of an RF layer. In this way they differ from our electro-optical polymers and are considered more advanced next-generation materials.

Our revenue model relies substantially on the assumption that we will be able to successfully develop non-linear polymer materials and photonic device products, which will use non-linear all-optical and electro-optic polymers for applications within the industries named below. When appropriate, we intend to create specific materials for each of these applications and use our proprietary knowledge base to continue to enhance its discoveries.

telecommunications/data communications

backplane optical interconnects

cloud computing and data centers

photovoltaic cells

medical applications

satellite reconnaissance

navigation systems

radar applications

optical filters

spatial light modulators

all-optical transistors

entertainment

To be successful, we must, among other things:

Develop and maintain collaborative relationships with strategic partners;

Continue to expand our research and development efforts for our products;

Develop and continue to improve on our manufacturing processes and maintain stringent quality controls;

Produce commercial quantities of our products at commercially acceptable prices;

Rapidly respond to technological advancements;

Attract, retain and motivate qualified personnel; and

Obtain and retain effective intellectual property protection for our products and technology.

We believe that Moore's Law (a principle which states the number of transistors on a silicon chip doubles approximately every eighteen months) will create markets for our high-performance electro-optic materials and photonic device products.

Plan of Operation

Since inception, we have been engaged primarily in the research and development of photonic devices and organic nonlinear polymer materials and associated products. We are devoting significant resources to engineer next-generation electro-optic polymers for future applications to be utilized by electro-optic device manufacturers, such as telecommunications component and systems manufacturers, networking and switching suppliers, semiconductor companies, aerospace companies, government agencies and internal device development. We expect to continue to develop products that we intend to introduce to these rapidly changing markets and to seek to identify new markets. We expect to continue to make significant operating and capital expenditures for research and development activities.

As we move from a development stage company to a product supplier, we expect that our financial condition and results of operations will undergo substantial change. In particular, we expect to record both revenue and expense from product sales, to incur increased costs for sales and marketing and to increase general and administrative expense. Accordingly, the financial condition and results of operations reflected in our historical financial statements are not expected to be indicative of our future financial condition and results of operations.

Some of our more significant milestones that we achieved during 2013 and 2014 include:

In February 2013 we delivered to a potential large system supplier customer prototype devices that were coated with our advanced organic nonlinear electro-optical polymer, Perkinamine Indigo^TM. Tests conducted by the University of Colorado, Boulder on coupons coated with the material demonstrated consistent R₃₃ measurements from 100-125 picometers per volt at 1550 nm, which as tested by the University of Colorado exceeded the potential large system supplier customer's stated requirements.

In March 2013 we entered into a product development contractor agreement with EM Photonics (EMP) of Newark, Delaware to fabricate and test waveguides and phase modulators during an initial development phase using existing EMP polymer modulator design and processes. In June 2013 we consolidated the EMP design program into our University of Colorado, Boulder (UCB) program after we fabricated structures with UCB that will be used as the basic building blocks of our Integrated Optical Device effort for the construction of both our advanced telecom modulator and data communications transceiver

In April 2013 our potential large system supplier customer informed us that their preliminary testing results on the prototype devices coated with Perkinamine Indigo™ that we delivered to them in February 2013 demonstrated several of the key performance parameters that they desired. There are still additional tests that need to be completed. We are continuing to engage with our potential customer utilizing our Perkinamine^TM family of chromophores in a number of host polymers and will evaluate these polymers in conjunction with our chromophores for a specific performance attributes for their application.

In April 2013 Japan granted our Company Japanese Patent No. 5241234 entitled Heterocyclical Chromophore Architectures. This patent protects the unique molecular structures that give our chromophores the thermal stability necessary to withstand CMOS processing temperatures without compromising electro-optical effects.

In June 2013 we signed a new agreement with Lincoln Park Capital Fund, LLC (“Lincoln Park”) to sell up to $20 million of common stock. Under the agreement subject to certain conditions and at our sole discretion, Lincoln Park has committed to invest up to $20 million in the Company’s common stock over a 30-month period. In October 2013 the U.S. Securities and Exchange Commission declared effective our registration statement covering the resale of the shares that may be issued to Lincoln Park. Sales of shares will be made in specified amounts and at prices that are based upon the market prices of our Company's common stock.

In August 2013 in a combined effort of the Company’s chemists, the University of Colorado, Boulder, and a third party research group we successfully fabricated Silicon Organic Hybrid (SOH) slot waveguide modulators. The devices utilize an existing modulator structure with one of our proprietary electro-optic polymer material systems as the enabling material layer. In October 2013 we confirmed the functionality of the SOH slot waveguide modulators as operating prototype devices. These first-generation devices have achieved greater electro-optical activity and dramatically lower drive voltage than industry standard modulators based on inorganic materials.

In November 2013 preliminary testing and initial data on our SOH slot waveguide modulators demonstrated several promising characteristics. The tested SOH chip had a 1-millimeter square footprint, enabling the possibility of sophisticated integrated optical circuits on a single silicon substrate. In addition, the waveguide structure was approximately 1/20 the length of a typical inorganic-based silicon photonics modulator waveguide. With the combination of our proprietary electro-optic polymer material and the extremely high optical field concentration in the slot waveguide modulator, the test modulators demonstrated less than 2.2 volts to operate. Initial data rates exceeded 30-35 Gb/sec in the telecom, 1550 nanometer frequency band. This is equivalent to four, 10Gb/sec, inorganic, lithium niobate modulators that would require approximately 12-16 volts to move the same amount of information. Our material also operates in the 1310 nanometer frequency band, which is suitable for data communications applications.

In February 2014 we received our first purchase order for our advanced organic nonlinear electro-optic (EO) polymer from Boulder Nonlinear Systems (BNS) of Boulder, Colorado in connection with the development of a next generation LADAR system. It is a radar system that utilizes a pulse laser to calculate the distance to a target, but is also capable of rendering a 3-D image.

In March 2014 we began the process of manufacturing an advanced design Silicon Organic Hybrid Transceiver prototype and have released the completed chip design to the OpSIS Center at the University of Delaware who will be producing initial silicon chips through their fabrication partner (IME) in Singapore. Delivery of the chips was expected in early summer 2014 for qualification and testing. We were notified that the delivery of these chips has been delayed until late fall. The OpSIS Center at the University of Delaware will be providing us with chips that we will process with various combinations of our electro-optic polymer systems. The initial application will target inter-data center interconnections of more than 10 kilometers. Our next design will utilize a different frequency and address the current bottleneck in the rack-to-server layer.

In April 2014, we entered into a sole worldwide license agreement with Corning Incorporated enabling us to integrate Corning's organic electro-optical chromophores into our portfolio of electro-optic polymer materials. The agreement allows us to use the licensed patents within a defined license field that includes communications, computing, power, and power storage applications utilizing the nonlinear optical properties of their materials. As a result of obtaining this license agreement, we created a new powerful and durable nonlinear organic electro-optical (EO) material that will be used in photonic device development and is based on our new multi-chromophore approach that allows two or more chromophores to work in concert. This multi-chromophore system has achieved a 50% increase in chromophore concentration, leading to higher electro-optical activity when compared to an equivalent single chromophore system. Further, the system does not cause the high chromophore density loading issues such as reduced effective electro-optic activity due to a non-uniform concentration of chromophore in the polymer host. Repeated, multi-point measurements of the multi-chromophore system show twice the electro-optic effect of Lithium Niobate with excellent durability.

In August 2014 we completed a Regulation D Rule 506 private placement offering solely to accredited investors of units, with each unit consisting of 67,000 shares of our common stock and a Warrant to purchase 33,500 shares of common stock at $1.00 per share and 33,500 shares of common stock at $1.25 per share, for $50,000 per Unit, or approximately $0.75 per share of common stock. We also simultaneously completed a Regulation S private placement offering of Units having the same terms as the Regulation D, and in total, the Company sold 62.8 Units for total proceeds to us in both offerings equal to $3,140,000.

In August 2014 we announced that the University of Colorado successfully fabricated and tested a bleached electro-optic waveguide modulator designed and fabricated through a sponsored collaborative research agreement. The results of this initial bleached waveguide modulator correlated well with previous electro-optic thin film properties.

In October 2014 we announced that we would subject our pilot run of bleached waveguide modulators to performance testing. At that time, we submitted an order with Reynard Corporation in San Clemente, California to produce gold-layered fused silica substrates for our bleached waveguide modulators to be coated with several of the Company's organic electro-optical polymers. We received delivery of the substrates in early November for processing of additional bleached waveguide modulators, which will be subjected to performance tests throughout December 2014. The Company anticipates testing will validate the previous modulator results from August 2014, and the viability of its device design and materials systems at nominal speeds in this type of modulator design.

Also, in October 2014, we announced we procured and received chips produced by IMEC International of various types of passive, silicon photonic modulators and waveguides structures to baseline their performance. Similar silicon photonic chips capable of being coated with the Company's advanced organic electro-optically active polymers will then be tested when we receive them from OpSIS, which is scheduled for a late November delivery. This process will be used to compare and contrast side-by-side performance of similar device structures to show anticipated performance improvements obtained by coating passive photonic devices with Lightwave's active materials. Results are expected to demonstrate improved data transfer speeds over current technologies.

During the last several months, we have engaged with various Tier 1 system integrators, device, module and subsystem manufacturers in an effort to identify potential, mutually beneficial joint development programs. We now have several mutual NDAs in place with these entities and are exploring numerous opportunities in the coming months.

We ultimately intend to use our next-generation non-linear all-optical and electro-optic polymers for future applications vital to the following industries. We expect to create specific materials for each of these applications as appropriate:

telecommunications/data communications

backplane optical interconnects

cloud computing and data centers

photovoltaic cells

medical applications

satellite reconnaissance

navigation systems

radar applications

optical filters

spatial light modulators

all-optical transistors

entertainment

In an effort to maximize our future revenue stream from our non-linear all-optical and electro-optic polymer products, our business model anticipates that our revenue stream will be derived from one or some combination of the following: (i) technology licensing for specific product applications; (ii) joint venture relationships with significant industry leaders; or (iii) the production and direct sale of our own electro-optic device components. Our objective is to be a leading provider of proprietary technology and know-how in the photonic device markets. In order to meet this objective, subject to successful testing of our technology and having available financial resources, we intend to:

Develop non-linear all-optical and electro-optic polymers and photonic devices;

Continue to develop proprietary intellectual property;

Streamline our product development process;

Develop a comprehensive marketing plan;

Maintain/develop strategic relationships with government agencies, private firms, and academic institutions; and

Continue to attract and retain high-level science and technology personnel to our Company.

Our Proprietary Products in Development

As part of a two-pronged marketing strategy, our Company is developing several devices, which are in various stages of development that utilize our organic nonlinear optical materials.

They include:

datacom/telecomm photonic transceiver

telecommunications modulator

spatial light modulator

optical filter

all-optical switch

multi-channel optical modem

Additionally, we must create an infrastructure, including operational and financial systems, and related internal controls, and recruit qualified personnel. Failure to do so could adversely affect our ability to support our operations.

Capital Requirements

As a development stage company, we do not generate revenues. We have incurred substantial net losses since inception. We have satisfied our capital requirements since inception primarily through the issuance and sale of our common stock. During 2013 we received $2,351,008 in cash proceeds from the issuance and sale of our common stock. During the first three quarters of 2014 we received $4,329,978 in cash proceeds from the issuance and sale of our common stock.

Results of Operations

Comparison of three months ended September 30, 2014 to three months ended September 30, 2013

Revenues

As a development stage company, we had no revenues during the three months ended September 30, 2014 and September 30, 2013. The Company is in various stages of material and photonic device development and evaluation with potential customers and strategic partners. We expect the next revenue stream to be in sale of nonlinear optical polymer materials, prototype devices, product development agreements prior to moving into production.

Operating Expenses

Our operating expenses were $1,160,723 and $997,760 for the three months ended September 30, 2014 and 2013, respectively, for an increase of $162,963. This increase in operating expenses was due primarily to increases in research and development salaries and wages, laboratory material testing expense and electro-optic device development, research and development non-cash stock option and warrant amortization, rent and utilities expenses, license fees, research and development consulting fees, office expenses, shareholder annual meeting, professional fees, legal fees, accounting and auditing fees, human resource support and 401(k) Plan processing fees and software expenses offset by decreases in general and administrative non-cash stock option and warrant amortization, investor relations expenses and travel expenses.

Included in our operating expenses for the three months ended September 30, 2014 was $741,464 for research and development expenses compared to $580,403 for the three months ended September 30, 2013, for an increase of $161,061. This is primarily due to increases in research and development salaries and wages, laboratory material testing expense and electro-optic device development, research and development non-cash stock option and warrant amortization, rent and utilities expenses, license fees and consulting fees offset by decreases in travel expenses.

Research and development expenses currently consist primarily of compensation for employees engaged in internal research, product and application development activities; laboratory operations, internal and outsourced material and device testing and prototype electro-optic device design, development and processing work; customer testing; fees; costs; and related operating expenses.

We expect to continue to incur substantial research and development expense to develop and commercialize our electro-optic material platform. These expenses will increase as a result of accelerated development effort to support commercialization of our non-linear optical polymer materials technology; outsourcing work to build device prototypes; expanding and equipping in-house laboratories; hiring additional technical and support personnel; engaging a senior technical advisor; pursuing other potential business opportunities and collaborations; customer testing and evaluation; and incurring related operating expenses.

Wages and salaries, including benefits increased $51,005 from $207,189 for the three months ended September 30, 2013 to $258,194 for the three months ended September 30, 2014.

Laboratory material testing expense and electro-optic device development increased $40,166 from $162,991 for the three months ended September 30, 2013 to $203,155 for the three months ended September 30, 2014.

Research and development non-cash stock option amortization increased $24,026 from $94,614 for the three months ended September 30, 2013 to $118,640 for the three months ended September 30, 2014.

Rent and utilities increased $19,913 from $19,498 for the three months ended September 30, 2013 to $39,411 for the three months ended September 30, 2014 due to the lease of the new Colorado corporate office, optical lab facility and clean room.

License fees increased $15,000 for the three months ended September 30, 2014 compared to zero for the three months ended September 30, 2013 for the license fee paid to Corning in accordance with a worldwide sole license agreement.

Consulting expenses increased $10,500 from $0 for the three months ended September 30, 2013 to $10,500 for the three months ended September 30, 2014.

Travel expenses decreased $7,629 from $19,539 for the three months ended September 30, 2013 to $11,910 for the three months ended September 30, 2014, primarily due to the relocation of the Company’s headquarters and optical lab to Colorado.

General and administrative expense consists primarily of compensation and support costs for management staff, and for other general and administrative costs, including executive, sales and marketing, investor relations, accounting and finance, legal, consulting and other operating expenses.

General and administrative expenses increased $1,902 to $419,259 for the three months ended September 30, 2014 compared to $417,357 for the three months ended September 30, 2013. The increase is primarily due to increases in office expenses, shareholder annual meeting, professional fees, legal fees, accounting and auditing fees, human resource support and 401(k) Plan processing fees and software expenses offset by decreases in general and administrative non-cash stock option and warrant amortization, investor relations expenses, rent and utilities and travel expenses.

Office expenses increased $12,452 to $21,352 for the three months ending September 30, 2014 from $8,900 for the three months ended September 30, 2013 for the office expenses of the new facility in Colorado.

Shareholder annual meeting expenses increased $11,340 to $38,749 for the three months ending September 30, 2014 from $27,409 for the three months ended September 30, 2013.

Professional fees increased $10,500 to $10,500 for the three months ending September 30, 2014 from $0 for the three months ended September 30, 2013.

Legal fees increased $8,566 to $70,627 for the three months ending September 30, 2014 from $62,061 for the three months ended September 30, 2013 primarily due to the 2014 private placement.

Accounting and auditing fees increased $3,587 to $39,400 for the three months ending September 30, 2014 from $35,813 for the three months ended September 30, 2013.

Human resource support and 401(k) Plan processing fees increased $3,391 to $4,229 for the three months ending September 30, 2014 from $838 for the three months ended September 30, 2013.

Software expenses increased $3,174 to $3,623 for the three months ending September 30, 2014 from $449 for the three months ended September 30, 2013 primarily for the implementation, of an employee stock option software program for interactive option exercises by employees and directors under the 2007 Employee Stock Plan.

General and administrative non-cash stock option and warrant amortization decreased $28,265 to $49,177 for the three months ending September 30, 2014 from $77,442 for the three months ended September 30, 2013.

Investor relation expenses decreased $11,614 to $0 for the three months ending September 30, 2014 from $11,614 for the three months ended September 30, 2013.

Rent and utilities decreased $7,400 to ($3,500) for the three months ending September 30, 2014 from $3,900 for the three months ended September 30, 2013 since previous expenses were allocated to research and development for the optical lab in the Colorado facility.

Travel expenses decreased $5,583 to $8,442 for the three months ending September 30, 2014 from $14,025 for the three months ended September 30, 2013, primarily due to the relocation of the Company’s headquarters and optical lab to Colorado.

We expect general and administrative expense to increase in future periods as we increase the level of corporate and administrative activity, including increases associated with our operation as a public company; and significantly increase expenditures related to the future production and sales of our products.

Other Income (Expense)

Other expense increased $13,929 to ($13,866) for the three months ending September 30, 2014 from $63 for the three months ending September 30, 2013, relating primarily to the commitment fee associated with the purchase of shares by an institutional investor for sale under a stock purchase agreement during the corresponding three-month period.

Net Loss

Net loss was $1,174,589 and $997,697 for the three months ended September 30, 2014 and 2013, respectively, for an increase of $176,892, was due primarily to increases in research and development salaries and wages, laboratory material testing expense and electro-optic device development, research and development non-cash stock option and warrant amortization, rent and utilities expenses, license fees, research and development consulting fees, office expenses, shareholder annual meeting, professional fees, legal fees, accounting and auditing fees, human resource support and 401(k) Plan processing fees, software expenses and commitment fee associated with the purchase of shares by an institutional investor for sale under a stock purchase agreement offset by decreases in general and administrative non-cash stock option and warrant amortization, investor relations expenses and travel expenses.

Comparison of nine months ended September 30, 2014 to nine months ended September 30, 2013

Revenues

As a development stage company, we had revenues of $2,500 during the nine months ended September 30, 2014 and $0 for the nine months ending September 30, 2013. The Company is in various stages of material and photonic device development and evaluation with potential customers and strategic partners. We expect the next revenue stream to be in sale of nonlinear optical polymer materials, prototype devices, product development agreements prior to moving into production.

Operating Expenses

Our operating expenses were $3,159,697 and $2,865,262 for the nine months ended September 30, 2014 and 2013, respectively, for an increase of $294,435. This increase in operating expenses was due primarily to increases in research and development salaries and wages, laboratory electro-optic device prototype, development and outsourced testing expenses, laboratory materials and supplies, research and development non-cash stock option and warrant amortization, license fees, rent and utility expenses, depreciation, legal expenses, office expenses, software expense, professional fees, annual shareholder meeting expense, human resource support and 401(k) Plan processing fees, moving expenses and investor relations expenses offset by decreases in general and administrative non-cash amortization of options and warrants, general and administrative wages and salaries, travel and lodging expenses and internet web design fees.

Included in our operating expenses for the nine months ended September 30, 2014 was $1,945,357 for research and development expenses compared to $1,566,901 for the nine months ended September 30, 2013, for an increase of $378,456. This is primarily due to increases in research and development salaries and wages, laboratory electro-optic devices prototype, development and outsourced testing expenses, laboratory materials and supplies, research and development non-cash stock option and warrant amortization, license fees, rent, depreciation and moving expenses.

Wages and salaries and benefits increased $121,233 from $608,372 for the nine months ended September 30, 2013 to $729,605 for the nine months ended September 30, 2014 primarily due to additional employees hired to perform in-house material development, testing and device design and development.

Laboratory material testing expense and electro-optic device development increased $71,887 from $296,843 for the nine months ended September 30, 2013 to $368,730 for the nine months ended September 30, 2014. Laboratory materials and supplies also increased $37,552 from $62,236 for the nine months ended September 30, 2013 to $99,788 for the nine months ended September 30, 2014.

Non-cash stock compensation and stock option and warrant amortization increased $79,626 from $321,251 for the nine months ended September 30, 2013 to $400,877 for the nine months ended September 30, 2014.

License fees increased $15,000 for the nine months ended September 30, 2014 compared to zero for the nine months ended September 30, 2013 for the license fee paid to Corning in accordance with a worldwide sole license agreement.

Rent expense increased $21,201 from $58,509 for the nine months ended September 30, 2013 to $79,710 for the nine months ended September 30, 2014 due to the lease of the new Colorado corporate office, optical lab facility and clean room.

Depreciation expense increased $13,535 from $81,446 for the nine months ended September 30, 2013 to $94,981 for the nine months ended September 30, 2014 primarily due to the additional equipment purchased for the Company’s Delaware and Colorado laboratory facilities.

Moving expenses incurred during the nine months ending September 30, 2014, for the move of the optical lab to the Company’s new headquarters facility in Colorado were $3,972.

General and administrative expenses decreased $84,021 to $1,214,340 for the nine months ended September 30, 2014 compared to $1,298,361 for the nine months ended September 30, 2013. The decrease is due primarily to decreases in general and administrative non-cash amortization of options and warrants, general and administrative wages and salaries, travel expenses and internet web design fees offset by increases in legal fees, office expenses, software expense, professional fees, annual shareholder meeting expense, human resource support and 401(k) Plan processing fees, general and administrative moving expenses, rent and utility expenses and investor relations expenses.

Compensation including fringe benefits decreased $38,747 to $399,791 for the nine months ending September 30, 2014 from $438,538 for the nine months ending September 30, 2013. Also, general and administrative non-cash stock option and warrant amortization decreased by $121,414 to $184,830 for the nine months ended September 30, 2014 compared to $306,244 for the nine months ended September 30, 2013.

Travel expenses were $39,743 and $66,507 for the nine months ended September 30, 2014 and 2013. The decrease of $26,764 was primarily due to the relocation of the Company’s headquarters and optical lab to Colorado.

Internet and web design fees decreased $6,818 to $7,369 for the nine months ended September 30, 2014 compared to $14,187 for the nine months ended September 30, 2013 due to the web design revisions made during 2013.

Legal fees were $177,355 and $151,333 for the nine months ended September 30, 2014 and 2013 for an increase of $26,022 for legal fees in connection with capital raise documents and registration statements filed during 2014.

Office expenses including administrative and receptionist expenses increased $23,257 from $19,161 for the nine month period ended September 30, 2013 to $42,418 for the nine month period ended September 30, 2014 for expenses related to the Company’s new headquarters in Colorado.

Software expenses increased $11,110 from $450 for the nine months ended September 30, 2013 to $11,560 for the nine months ended September 30, 2014 primarily for the implementation during the second quarter of 2013, of an employee stock option software program for interactive option exercises by employees and directors under the 2007 Employee Stock Plan.

Professional fees increased $9,475 from $7,590 for the nine months ended September 30, 2013 to $17,065 for the nine months ended September 30, 2014.

Expenses for the annual shareholder meeting increased $9,169 from $29,580 for the nine months ended September 30, 2013 to $38,749 for the nine months ended September 30, 2014.

Human resource support and 401(k) Plan processing fees increased $8,423 from $2,383 for the nine month period ended September 30, 2013 to $10,806 for the nine month period ended September 30, 2014 for the implementation of a 401(k) Plan in the fourth quarter of 2013.

Moving expenses incurred during the nine months ending September 30, 2014, for the move of the Company’s corporate office to the new headquarter facility in Colorado were $7,736.

Rent and utility expenses increased $5,530 from $11,700 for the nine months ended September 30, 2013 to $17,230 for the nine months ended September 30, 2014 primarily for the expenses of the new headquarter facility in Colorado.

Investor relations expenses increased by $5,166 from $11,644 for the nine months ended September 30, 2013 to $16,810 for the nine months ended September 30, 2014.

Other Income (Expense)

Other income (expense) decreased $187,585 to ($16,484) for the nine months ending September 30, 2014 from ($204,069) for the nine months ending September 30, 2013, relating primarily to the commitment fee associated with the purchase of shares by an institutional investor for sale under a stock purchase agreement during the corresponding nine-month period.

Net Loss

Net loss was $3,173,681 and $3,069,331 for the nine months ended September 30, 2014 and 2013, respectively, for an increase of $104,350, due primarily to increases in research and development salaries and wages, laboratory electro-optic device prototype, development and outsourced testing expenses, laboratory materials and supplies, research and development non-cash stock option and warrant amortization, license fees, depreciation, legal expenses, office expenses, software expense, professional fees, annual shareholder meeting expense, human resource support and 401(k) Plan processing fees, moving expenses, rent and utility expenses and investor relations expenses offset by decreases in commitment fee associated with the purchase of shares by an institutional investor for sale under a stock purchase agreement, general and administrative non-cash amortization of options and warrants, general and administrative wages and salaries, travel and lodging expenses and internet web design fees.

Significant Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates based upon historical experience and various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our actual results may differ materially from these estimates.

We believe our significant accounting policies affect our more significant estimates and judgments used in the preparation of our financial statements. Our Annual Report on Form 10-K for the year ended December 31, 2013 contains a discussion of these significant accounting policies. We adopted changes to our significant accounting policies since December 31, 2013. See our Note 1 in our unaudited financial statements for the nine months ended September 30, 2014, as set forth herein for a complete discussion of our Company’s accounting policies.

Liquidity and Capital Resources

During the nine months ended September 30, 2014, net cash used in operating activities was $2,112,359 and net cash used in investing activities was $274,450, which was due primarily to the Company’s research and development activities and general and administrative expenditures. Net cash provided by financing activities for the nine months ended September 30, 2014 was $4,329,978. At September 30, 2014, our cash and cash equivalents totaled $4,213,873, our assets totaled $5,391,632, our liabilities totaled $502,134, and we had stockholders’ equity of $4,889,498.

Sources and Uses of Cash

Our future expenditures and capital requirements will depend on numerous factors, including: the progress of our research and development efforts; the rate at which we can, directly or through arrangements with original equipment manufacturers, introduce and sell products incorporating our polymer materials technology; the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; market acceptance of our products and competing technological developments; and our ability to establish cooperative development, joint venture and licensing arrangements. We expect that we will incur approximately $3,300,000 of expenditures over the next 12 months. Our cash requirements are expected to increase at a rate consistent with the Company’s path to revenue growth as we expand our activities and operations with the objective of commercializing our electro-optic polymer technology during 2015.

Our business does not presently generate the cash needed to finance our current and anticipated operations. We believe we have raised sufficient capital to finance our operations through December 2015, however, we will need to obtain additional future financing after that time to finance our operations until such time that we can conduct profitable revenue-generating activities.

Such future sources of financing may include cash from equity offerings, exercise of stock options, warrants and proceeds from debt instruments; but we cannot assure you that such equity or borrowings will be available or, if available, will be at rates or prices acceptable to us.

In May 2011 we signed our stock purchase agreement with Lincoln Park whereby subject to certain conditions and at our sole discretion, Lincoln Park has committed to purchase up to $20 million of our common stock over a 30-month period. We registered for resale by Lincoln Park 10,000,000 shares of our common stock in June 2011. The stock purchase agreement expired in December 2013. In June 2013 we signed our new stock purchase agreement with Lincoln Park to sell up to $20 million of common stock whereby subject to certain conditions and at our sole discretion, Lincoln Park has committed to purchase up to $20 million of our common stock over a 30-month period. We registered for resale by Lincoln Park 10,000,000 shares of our common stock in October 2013. Pursuant to the new stock purchase agreement, Lincoln Park is obligated to make purchases as the Company directs in accordance with the purchase agreement, which may be terminated by the Company at any time, without cost or penalty. Sales of shares will be made in specified amounts and at prices that are based upon the market prices of our Company's common stock immediately preceding the sales to Lincoln Park. We expect this financing to provide our Company with sufficient funds to maintain its operations for the foreseeable future. With the additional capital, we expect to achieve a level of revenues attractive enough to fulfill our development activities and adequate enough to support our business model for the foreseeable future. We cannot assure you that we will meet the conditions of the stock purchase agreement with Lincoln Park in order to obligate Lincoln Park to purchase our shares of common stock. In the event we fail to do so, and other adequate funds are not available to satisfy either short-term or long-term capital requirements, or if planned revenues are not generated, we may be required to substantially limit our operations. This limitation of operations may include reductions in capital expenditures and reductions in staff and discretionary costs.

There are no trading volume requirements or restrictions under the new stock purchase agreement, and we will control the timing and amount of any sales of our common stock to Lincoln Park. Lincoln Park has no right to require any sales by us, but is obligated to make purchases from us as we direct in accordance with the purchase agreement. We can also accelerate the amount of common stock to be purchased under certain circumstances. There are no limitations on use of proceeds, financial or business covenants, restrictions on future funding, rights of first refusal, participation rights, penalties or liquidated damages in the purchase agreement. We may terminate the stock purchase agreement at any time, at our discretion, without any penalty or cost to us. Lincoln Park may not assign or transfer its rights and obligations under stock the purchase agreement.

We expect that our cash used in operations will increase during 2014 and beyond as a result of the following planned activities:

The addition of management, sales, marketing, technical and other staff to our workforce;

Increased spending for the expansion of our research and development efforts, including purchases of additional laboratory and production equipment;

Increased spending in marketing as our products are introduced into the marketplace;

Developing and maintaining collaborative relationships with strategic partners;

Developing and improving our manufacturing processes and quality controls; and

Increases in our general and administrative activities related to our operations as a reporting public company and related corporate compliance requirements.

Analysis of Cash Flows

For the nine months ended September 30, 2014

Net cash used in operating activities was $2,112,359 for the nine months ended September 30, 2014, primarily attributable to the net loss of $3,173,681 adjusted by $119,036 in warrants issued for services, $466,671 in options issued for services, $24,862 in common stock issued for services, $110,054 in depreciation expenses and patent amortization expenses, $(39,259) in prepaid expenses and $379,958 in accounts payable and accrued expenses. Net cash used in operating activities consisted of payments for research and development, legal, professional and consulting expenses, rent and other expenditures necessary to develop our business infrastructure.

Net cash used by investing activities was $274,450 for the nine months ended September 30, 2014, consisting of $70,261 in costs for intangibles, and $204,189 in asset additions, primarily for the new Colorado corporate office, Colorado clean room and Delaware lab facility.

Net cash provided by financing activities was $4,329,978 for the nine months ended September 30, 2014 and consisted of $3,140,000 proceeds from private place, $1,036,148 in proceeds from sale of common stock to an institutional investor and $153,830 from the exercise of options and warrants.

Inflation and Seasonality

We do not believe that our operations are significantly impacted by inflation. Our business is not seasonal in nature.

Item 4

Controls and Procedures

Evaluation of Disclosure Controls and Procedures. The Company’s management, with the participation of the Company’s Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of September 30, 2014. Based on this evaluation, the Company’s Principal Executive Officer and Principal Financial Officer concluded that, as of September 30, 2014 the Company’s disclosure controls and procedures were effective, in that they provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and is accumulated and communicated to the Company’s management, including the Company’s Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting during the quarter ended September 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds


Date		Security/Value

July 2014		Common Stock – 2,081 shares of common stock at $0.96 per share issued for services.

August 2014		Common Stock – 1,897 shares of common stock at $1.05 per share issued for services.

September 2014		Common Stock – 2,121 shares of common stock at $0.94 per share issued for services.

August 2014		Unit – 67,000 shares of common stock and warrants to purchase 67,000 shares of common stock contained in units for total proceeds of $50,000.

August 2014		Warrant – right to buy 100,000 shares of common stock at $0.95 per share issued for services.

No underwriters were utilized and no commissions or fees were paid with respect to any of the above transactions. We relied on Section 4(a)(2) of the Securities Act of 1933, as amended, since the transactions did not involve any public offering.

Item 5

Other Information

On May 23, 2014, the Company’s board of directors appointed George Lauro as a member of the Company’s Operation Committee to serve for a period of not more than 120 days. On November 6, 2014, the Company’s board of directors retroactively extended Mr. Lauro’s service on the Company’s Operation Committee for an additional 7 months.

Item 6

Exhibits

The following exhibits are included herein:


Exhibit No.	Description of Exhibit	Location
10.1	Form of Subscription Agreement (Regulation D)	*
10.2	Form of Subscription Agreement (Regulation S)	*
10.3	Form of Warrant (Regulation D)	*
10.4	Form of Warrant (Regulation S)	*
31.1	Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, executed by the Principal Executive Officer of the Company.	Filed herewith
31.2	Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, executed by the Principal Financial Officer of the Company.	Filed herewith
32.1	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by the Principal Executive Officer of the Company.	Filed herewith
32.2	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by the Principal Financial Officer of the Company.	Filed herewith
101	XBRL	Furnished herewith

* Incorporated by reference to the Company's Form 8-K as filed with the SEC on July 14, 2014

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

LIGHTWAVE LOGIC, INC.

Registrant


By:	/s/ Thomas E. Zelibor
	Thomas E. Zelibor,
	Chief Executive Officer
	(Principal Executive Officer)

Date: November 14, 2014


By:	/s/ James S. Marcelli
	James S. Marcelli,
	President, Chief Operating Officer
	(Principal Financial Officer)

Date: November 14, 2014